Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2006 | $87,250 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | $350,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2008 | $30,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2004 | $100,000 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $1,000,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2006 | $1,250,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $1,384,120 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $404,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $668,300 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $3,000,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2007 | $500,000 | | grant |
McNeil Consumer Healthcare Division of McNEll-PPC, | Johnson & Johnson | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
ABRAXIS BIOSCIENCE LLC | Bristol-Myers Squibb | Illinois | local | 2012 | undisclosed | | property tax abatement |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2014 | $3,398,678 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2015 | $3,701,242 | | tax credit/rebate |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2016 | $4,515,115 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $83,752 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2018 | $39,409 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2019 | $39,219 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $39,219 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2020 | $180,014 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $47,739 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $110,366 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $302,558 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $581,555 | | tax credit/rebate |
Eli Lilly | Eli Lilly | Indiana | multiple | 1999 | $214,000,000 | | MEGADEAL |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2010 | $1,250,000 | | tax credit/rebate |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $2,000,000 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | | tax credit/rebate |
Eli Lilly dba Elanco Animal Health | Eli Lilly | Indiana | state | 2013 | $500,000 | | grant |
Disetronic Medical Systems, Incorporated | Roche | Indiana | state | 2005 | $20,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2007 | $101,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2008 | $200,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2009 | $310,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2009 | $137,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2010 | $50,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2011 | $200,000 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $300,000 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2012 | $50,000 | | training reimbursement |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $600,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
Johnson & Johnson Health Care Systems Inc. | Johnson & Johnson | Indiana | state | 2020 | $2,250,000 | | tax credit/rebate |
Johnson & Johnson Health Care Systems Inc. | Johnson & Johnson | Indiana | state | 2010 | $300,000 | | tax credit/rebate |
Elanco Animal Health Inc | Elanco Animal Health | Indiana | multiple | 2020 | $163,100,000 | | MEGADEAL |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $9,750,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $12,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Indiana | state | 2022 | $293,100,000 | | MEGADEAL |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2006 | $165,000 | | grant/loan hybrid program |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $500,000 | | grant/loan hybrid program |
Fort Dodge Laboratories, Inc. | Zoetis | Iowa | state | 2007 | $2,617,500 | | enterprise zone |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | | enterprise zone |
NewLink Genetics, Inc. | Lumos Pharma | Iowa | state | 2004 | $6,000,000 | | grant |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $3,500,000 | | grant |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2004 | $414,200 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | Iowa | state | 2007 | $466,425 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,975,500 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,000,000 | | infrastructure assistance |
Pfizer Inc & Subsidiaries | Pfizer | Iowa | state | 2010 | $942,184 | | tax credit/rebate |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $400,000 | | grant/loan hybrid program |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2008 | $80,172 | | training reimbursement |
Novartis Animal Health US Inc. | Novartis | Iowa | state | 2004 | $191,891 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2007 | $49,130 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2009 | $116,970 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2010 | $158,808 | | training reimbursement |
BioProtection Systems Corporation | Lumos Pharma | Iowa | state | 2007 | $71,101 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2011 | $55,629 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2008 | $57,716 | | training reimbursement |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $3,239,000 | | grant |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2015 | $1,330,020 | | tax credit/rebate |
Zoetis, Inc. and Subsidiaries | Zoetis | Iowa | State | 2017 | $2,499,000 | | Tax credit |
Cambrex Charles City, Inc. | Cambrex | Iowa | State | 2017 | $300,898 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $494,275 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2017 | $502,233 | | training reimbursement |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Newlink Genetics Corporation | Lumos Pharma | Iowa | state | 2014 | $200,071 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | | training reimbursement |
Hospira, Inc. | Pfizer | Kansas | state | 2006 | $68,770 | | training reimbursement |
Hospira, Inc. | Pfizer | Kansas | state | 2007 | $190,000 | | training reimbursement |
SAFC Biosciences | Merck KGaA (EMD) | Kansas | state | 2011 | $12,960 | | training reimbursement |
Hospira, Inc. | Pfizer | Kansas | state | 2007 | $103,000 | | grant |